Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.66 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.66 |
| ▸ | BCAT2 | O15382 | 1/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.59 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.58 |
| ▸ | LMNA | P02545 | 2/20 | 0.58 |
| ▸ | KDR | P35968 | 1/20 | 0.55 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.55 |
| ▸ | HTT | P42858 | 4/20 | 0.55 |
| ▸ | HPGD | P15428 | 3/20 | 0.55 |
| ▸ | MEN1 | O00255 | 2/20 | 0.55 |
| ▸ | NPC1 | O15118 | 2/20 | 0.55 |
| ▸ | RAB9A | P51151 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | F2R | P25116 | 1/20 | 0.53 |
| ▸ | SLC16A3 | O15427 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6271944 | 0.95 | ALDH1A1 (0.68) | ALDH1A1ADRB2BCAT2CYP3A4CYP2C19 | |
| SCHEMBL5595491 | 0.89 | ALDH1A1 (0.71) | ALDH1A1ADRB2BCAT2CYP3A4CYP2C19 | |
| SCHEMBL30742579 | 0.85 | TRPV1 (0.56) | ALDH1A1ADRB2BCAT2CYP3A4CYP2C19 | |
| Propylformate SCHEMBL28300667 | 0.85 | ALDH1A1 (0.49) | ALDH1A1ADRB2BCAT2CYP3A4CYP2C19 | |
| SCHEMBL19259498 | 0.84 | BCAT2 (0.72) | ALDH1A1ADRB2BCAT2CYP3A4CYP2C19 | |
| SCHEMBL1545821 | 0.83 | HTT (0.49) | HTTSLC16A3 | |
| SCHEMBL15923268 | 0.83 | HTT (0.49) | ALDH1A1KDM4EHTTHPGDMEN1 | |
| SCHEMBL7589245 | 0.82 | HTT (0.45) | ALDH1A1ADRB2CYP3A4KDM4ESMN1; SMN2 | |
| SCHEMBL4433080 | 0.81 | LIPG (0.51) | HTTSLC16A3 | |
| SCHEMBL11039198 | 0.81 | LIPG (0.51) | ALDH1A1KDM4EHTTHPGDMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 162 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024133320-A1 | PROCESS FOR PRODUCING AN OVERMOLDED PART IN AN INJECTION MOLDING APPARATUS | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2024-06-27 | — | — | WO | disclosed |
| EP-3352964-B1 | METHOD OF INJECTION MOLDING USING RIBS AND PRODUCT | SABIC GLOBAL TECHNOLOGIES BV (NL) | 2023-12-06 | — | — | EP | disclosed |
| EP-3107730-B1 | MULTILAYER SHEET, METHODS FOR MAKING THE SAME, AND ARTICLES COMPRISING THE MULTILAYER SHEET | SABIC GLOBAL TECHNOLOGIES BV (NL) | 2023-11-15 | — | — | EP | disclosed |
| WO-2023119130-A1 | MULTIWALL SHEET INCLUDING AN ACOUSTIC RESONATOR | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2023-06-29 | — | — | WO | disclosed |
| WO-2023119132-A1 | MULTIMATERIAL SHEET | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2023-06-29 | — | — | WO | disclosed |
| EP-3224533-B1 | ENCLOSURE WITH A CONDENSATION-RESISTANT INTERIOR SURFACE | SABIC GLOBAL TECHNOLOGIES BV (NL) | 2023-04-05 | — | — | EP | disclosed |
| EP-2732107-B1 | A MULTIWALL SHEET, METHODS OF MAKING, AND ARTICLES COMPRISING THE MULTIWALL SHEET | SABIC GLOBAL TECHNOLOGIES BV (NL) | 2023-04-05 | — | — | EP | disclosed |
| US-11590829-B2 | Functional interlayers for vehicle glazing systems | TESLA, INC. (US) | 2023-02-28 | — | — | US | disclosed |
| EP-3344432-B1 | PROCESS FOR PRODUCING LONGER FIBERS IN INJECTION MOLDED SOLID PARTS BY DISSOLVING OF GAS DURING PLASTICIZING | SABIC GLOBAL TECHNOLOGIES BV (NL) | 2022-12-21 | — | — | EP | disclosed |
| CN-104870530-B | Polymers, articles comprising polymers, and methods of making and using the same | 沙伯基础全球科技有限公司 | 2022-09-16 | — | — | CN | disclosed |
| WO-2009016088-A1 | THE USE OF BENZAMIDE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS | F. HOFFMANN-LA ROCHE AG (CH) | 2009-02-05 | — | — | WO | disclosed |
| US-20090036420-A1 | BENZAMIDE DERIVATIVES AND THEIR USE FOR TREATING CNS DISORDERS | F. HOFFMANN-LA ROCHE AG (CH) | 2009-02-05 | — | — | US | disclosed |
| WO-2009009308-A1 | A WINDOW SHADE AND A MULTI-LAYERED ARTICLE, AND METHODS OF MAKING THE SAME | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2009-01-15 | — | — | WO | disclosed |
| US-20080014446-A1 | WINDOW SHADE AND A MULTI-LAYERED ARTICLE, AND METHODS OF MAKING THE SAME | GENERAL ELECTRIC COMPANY (US) | 2008-01-17 | — | — | US | disclosed |
| WO-2007114060-A1 | POLYCARBONATE-HYDROGENATED POLYBUTADIENE COPOLYMER, METHOD FOR PRODUCING SAME, AND POLYCARBONATE RESIN COMPOSITION USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2007-10-11 | — | — | WO | disclosed |
| US-20060078743-A1 | Window shade and a multi-layered article, and methods of making the same | CITIBANK, N.A., AS COLLATERAL AGENT | 2006-04-13 | — | — | US | disclosed |
| US-20050203237-A1 | Biocidal compositions and methods of making thereof | CITIBANK, N.A., AS COLLATERAL AGENT | 2005-09-15 | — | — | US | disclosed |
| US-20050202100-A1 | Biocidal compositions and methods of making thereof | CITIBANK, N.A., AS COLLATERAL AGENT | 2005-09-15 | — | — | US | disclosed |
| US-5780551-A | UNSYMMETRICALLY PROTECTED; FROM ONE OR MORE CONJUGATED DIENE OR ALKENYLAROMATIC COMPOUND | FMC CORPORATION (US) | 1998-07-14 | — | — | US | disclosed |
| WO-1997016465-A1 | TELECHELIC POLYMERS FROM MIXED INITIATOR | FMC CORPORATION (US) | 1997-05-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090036420-A1 | BENZAMIDE DERIVATIVES AND THEIR USE FOR TREATING CNS DISORDERS | GABBR1, GABBR2, CHRM2 | ALDH1A1 204/4885ADRB2 518/4885BCAT2 234/4885 |
| US-20050202100-A1 | Biocidal compositions and methods of making thereof | PIK3C3, PRKACG, PRKX | ALDH1A1 695/4885ADRB2 4509/4885BCAT2 1725/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.